Blog carnival: Challenges and proposed solutions to support a deluge of new CGT approvals
It’s exciting news that there are close to 2,000 advanced therapies currently in clinical trials around the world. But is it good news? It’s exciting to see how far the cell and gene therapy (CGT) industry has come and how quickly the pipeline is growing. It’s...Translational efficiency will be key for cell and gene therapies entering future markets
Josee Champagne is the co-founder and director of weCANtrial Consulting Group, Inc., a partner of the weCANtranslate Network; Associate Director of Clinical Development at Northern Therapeutics and UC-CISS Program Manager at the Ottawa Hospital Research Institute...For advanced therapies, the sky’s the limit
Phil Vanek is responsible for technical due diligence and evaluation of potential investments, as well as guiding operational, R&D and strategic initiatives carried out at portfolio companies. An entrepreneurial and strategic international business leader, Phil...The two biggest (unexpected) takeaways from Summer by Design 2023
Dr. Tyler J. Wenzel (Twitter: @TylerJWenzel, Instagram: @TylerJWenzel, LinkedIn: https://www.linkedin.com/in/tylerjwenzel/), is a postdoctoral fellow currently affiliated with the University of Saskatchewan (Canada), where he oversees the facility for the mass,...
Comments